AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Jansman, FGA Sleijfer, DT de Graaf, JC Coenen, JLLM Brouwers, JRBJ
Citation: Fga. Jansman et al., Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer, DRUG SAFETY, 24(5), 2001, pp. 353-367

Authors: van den Bemt, PMLA Joosten, P Risselada, A van den Boogaart, MHA Egberts, ACG Brouwers, JRBJ
Citation: Pmla. Van Den Bemt et al., Stabilization of oral anticoagulant therapy in hospitalized patients and characteristics associated with lack of stabilization, PHARM WORLD, 22(4), 2000, pp. 147-151

Authors: Fijn, R Brouwers, JRBJ Timmer, JW de Jong-van den Berg, LTW
Citation: R. Fijn et al., Rational pharmacotherapy and clinical practice guidelines - Theories and perspectives on implementing pharmacotherapeutic treatment guidelines, PHARM WORLD, 22(4), 2000, pp. 152-158

Authors: Fijn, R Engels, SAG Brouwers, JRBJ Knaap, RJ De Jong-Van den Berg, LTW
Citation: R. Fijn et al., Dutch Hospital Drug Formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines, BR J CL PH, 49(3), 2000, pp. 254-263

Authors: Jansman, FGA Sleijfer, DT Coenen, JLLM De Graaf, JC Brouwers, JRBJ
Citation: Fga. Jansman et al., Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer, DRUG SAFETY, 23(4), 2000, pp. 255-278

Authors: van den Bemt, PMLA Egberts, TCG de Jong-van den Berg, LTW Brouwers, JRBJ
Citation: Pmla. Van Den Bemt et al., Drug-related problems in hospitalised patients, DRUG SAFETY, 22(4), 2000, pp. 321-333

Authors: Fijn, R Stuurman-Bieze, AGG van den Berg, PB Brouwers, JRBJ de Graeff, PA de Jong-van den Berg, LTW
Citation: R. Fijn et al., Predictors for prophylactic antithrombotic prescribing in ischaemic heart disease and the impact of national guidelines, EUR J CL PH, 56(9-10), 2000, pp. 739-746

Authors: van Dijk, KN de Vries, CS van den Berg, PB Brouwers, JRBJ de Jong-van den Berg, LTW
Citation: Kn. Van Dijk et al., Drug utilisation in Dutch nursing homes, EUR J CL PH, 55(10), 2000, pp. 765-771

Authors: Fijn, R de Vries, CS Engles, SAG Brouwers, JRBJ de Blaey, CJ de Jong-van den Berg, LTW
Citation: R. Fijn et al., The quality of Dutch hospital drug formularies: Evaluation of technical features and organisational information, PHARM WORLD, 21(3), 1999, pp. 120-126

Authors: Fijn, R de Jong-van den Berg, LTW Brouwers, JRBJ
Citation: R. Fijn et al., Rational pharmacotherapy in The Netherlands: formulary management in Dutchhospitals, PHARM WORLD, 21(2), 1999, pp. 74-79

Authors: Fijn, R Brouwers, JRBJ Knaap, RJ De Jong-Van den Berg, LTW
Citation: R. Fijn et al., Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-widesurvey of structure, activities, and drug selection procedures, BR J CL PH, 48(2), 1999, pp. 239-246

Authors: Janknegt, R Pinckaers, JWM Rohof, MHC Ausems, MEM Arbouw, MEL van der Velden, RW Brouwers, JRBJ
Citation: R. Janknegt et al., Double-blind comparative study of droperidol, granisetron and granisetron plus dexamethasone as prophylactic anti-emetic therapy in patients undergoing abdominal, gynaecological, breast or otolaryngological surgery, ANAESTHESIA, 54(11), 1999, pp. 1059-1068
Risultati: 1-12 |